Clinical Research
New
Investigations Question Need for Cisplatin in Advanced NSCLC
(cancernetwork.com)
v.9, no.11, Suppl.6 Oncology News (November 2000)
Discusses the results of the European Organization for Research
and Treatment of Cancer trial (EORTC 08975) which compared the non-platinum
doublet gemcitabine (Gemzar) and paclitaxel (Taxol) with gemcitabine/cisplatin
and paclitaxel/cisplatin in patients with advanced NSCLC. Discusses the
ultimate goal of finding chemotherapeutic strategies that are as effective
as platinum- based therapy, but are better tolerated and more cost effective.
Registration required for free access. [11/00]
Cisplatin
- Recent MEDLINE Abstracts (PubMed)
Side Effects
Cisplatin
(Platinol) (CancerBACUP)
Factsheet describes cisplatin, how it is given and some of its possible
side effects. [11/02]
Neuroprotective
Effect of Vitamin E Supplementation in Patients Treated with Cisplatin
Chemotherapy (PubMed)
Abstract of a study published in the March 1, 2003 issue of the Journal
of Clinical Oncology to evaluate the neuroprotective effect of antioxidant
supplementation with Vitamin E in patients treated with cisplatin chemotherapy.
Concludes that Vitamin E supplementation of patients receiving cisplatin
chemotherapy decreases the incidence and severity of peripheral neurotoxicity.
[3/03]
|
